The Impacts of Prepared Plasma-Activated Medium (PAM) Combined with Doxorubicin on the Viability of MCF-7 Breast Cancer Cells: A New Cancer Treatment Strategy
Author(s) -
Setareh Zahedian,
Azadeh Hekmat,
Saeed Hesami Tackallou,
M. Ghoranneviss
Publication year - 2022
Publication title -
reports of biochemistry and molecular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.467
H-Index - 8
ISSN - 2322-3480
DOI - 10.52547/rbmb.10.4.640
Subject(s) - mcf 7 , doxorubicin , breast cancer , cancer , cancer research , oncology , medicine , chemotherapy , human breast
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom